Quercetin: a new hope for lung fibrosis?
NCT ID NCT07466420
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether quercetin, a natural compound found in many fruits and vegetables, can slow lung scarring and improve breathing in people with pulmonary fibrosis. Half of the 100 participants will take quercetin pills daily for 24 weeks, while the other half receive standard care. Researchers will measure changes in lung function, inflammation, and cellular aging markers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- quercetin (dietary supplement)
- What this could lead to
- If it works, this could point toward a simple, low-cost supplement to help manage fibrotic lung diseases and slow disease progression.
- What could go wrong
- This is an early-stage trial with only 100 participants. Quercetin is a supplement, not a proven treatment, and may show no benefit over standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROTIC INTERSTITIAL LUNGS DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Respiratory Department, University Hospital of Heraklion, School of Medicine, University of Crete
RECRUITINGHeraklion, Crete, 71500, Greece
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Beyond the lungs: the hidden emotional toll of IPF medications
- Can a new daily pill slow lung scarring in IPF?
- What makes someone stop a lung fibrosis drug? a study asks patients directly
- Which finger or earlobe? a study tests the best spot for oxygen monitoring in lung disease
- Can a new drug slow lung scarring in IPF?
- Blood tests could unlock early clues for three major lung diseases